A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Clinical trial NCT04840290 · UNKNOWN

Trial details

NCT number: NCT04840290
Sponsor: Tang-Du Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2019-06-01
Primary completion: 2023-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.